Exhibitors

Abbott

Abbott offers a broad scope of innovative and outcome-driven solutions for comprehensive heart failure treatment and management. Our products are designed to address the continuum of care—from monitoring for symptoms to advanced stage therapy. Our goal is to help you keep patients with heart failure moving forward with the best possible quality of life.

Agepha Pharma

Agepha Pharma is proud to present LODOCO (low dose colchicine) a once-daily, continuous-use oral treatment, that is now available for prescription in the U.S. as the first anti-inflammatory atheroprotective cardiovascular treatment demonstrated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients.

Alnylam Pharmaceuticals

Alnylam has led the translation of RNA interference into a new class of approved and investigational medicines for rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Learn more: www.alnylam.com.

Amgen

Amgen, a biotechnology company dedicated to developing innovative medicines for serious illnesses, including cardiovascular disease, with a bold ambition to halve the number of heart attacks and strokes by 2030.

AstraZeneca

AstraZeneca focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.

Boehringer Ingelheim

 

Boston Scientific

Boston Scientific, a global medical technology leader for over 40 years, transforms lives with innovative solutions that improve patient health and reduce healthcare costs.

Bristol Myers Squibb

Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular and neuroscience. Our employees work every day to transform patients’ lives through science.

Cytokinetics

Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised.

Heartflow

Heartflow is transforming precision coronary care with the only AI-powered, non-invasive integrated heart care solution across the CCTA pathway. Our non-invasive technologies have helped clinicians diagnose and manage over 400,000 patients.

Life Systems International

LSI leads the way in providing time-saving cardiac rehab monitoring and management solutions you trust, supported by relationships you rely on. LSI delivers customized solutions for your cardiac rehab’s advancement.

Medtronic

We lead global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. Expect more from us.

Milestone Pharma

Novartis Pharmaceuticals Corp

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

Novo Nordisk

Novo Nordisk is a leading global healthcare company committed to discovering and developing innovative medicines to help people living with serious chronic conditions and rare diseases lead longer, healthier lives.

Pfizer

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development, and manufacture of healthcare products, including innovative medicines and vaccines.

Regeneron

Regeneron is a leading biotechnology company that invents medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments, almost all of which were homegrown in our laboratories.